QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

NEW YORK, March 19 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes.

The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

    Autoimmune-Inflammation Index (HHA)
    Drop
     GW Pharmaceuticals, Inc (LSE:GWP.L)
     Human Genome Sciences (NASDAQ:HGSI)
     Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)
    Add
     Fornix Biosciences N.V. 
     Meda AB (SHSE1: MEDA A)
     Mitsubishi Tanabe Pharma Corporation 

    Cancer Index (HHK)
    Drop
     Shire PLC (NASDAQ:SHPGY)
    Add
     Ark Therapeutics Group Plc (LSE:AKT.L)

    Cardio Devices Index (HHE)
    Drop
     Biosphere Medical, Inc. (NASDAQ:BSMD)
    Add
     Zoll Medical Corp. (NASDAQ:ZOLL)

    Cardiology Index (HRD)
    Drop
     Encysive Pharmaceuticals, Inc. (NASDAQ:ENCY)
     Human Genome Sciences, Inc  (NASDAQ:HGSI)
     Vical, Inc (NASDAQ:VICL)
    Add
     Mitsubishi Tanabe Pharma Corporation 
     Sangamo BioSciences Inc (NASDAQ:SGMO)
     Sciele Pharma, Inc. (NASDAQ:SCRX)

    Composite Index (HHQ)
    Drop
     Advanced Medical Optics, Inc. (NYSE:EYE)
     Align Technology Inc. (NASDAQ:ALGN)
     Array Biopharma Inc. (NASDAQ:ARRY)
     ArthroCare Corp. (NASDAQ:ARTC)
     Endo Pharmaceuticals Hldgs. (NASDAQ:ENDP)
     Fresenius Medical Care AG (XETRA: FME.DE)
     GEDEON RICHTER RT (XETRA: R1G1.DE)
     GENMAB A/S (Copenhagen: GEN.CO)
     H. LUNDBECK A/S (Copenhagen: LUN.CO)
     Human Genome Sciences (NASDAQ:HGSI)
     Imclone Systems (NASDAQ:IMCL)
     Inverness Medical Innovations (AMEX:IMA)
     Invitrogen Corp. (NASDAQ:IVGN)
     Medarex Inc. (NASDAQ:MEDX)
     Medicis Pharmaceutical (NYSE:MRX)
     Mentor Corp. (NYSE:MNT)
     ONYX Pharmaceuticals Inc. (NASDAQ:ONXX)
     PDL BioPharma, Inc. (NASDAQ:PDLI)
     Pharmion Corp. (NASDAQ:PHRM)
     Progenics Pharmaceuticals Inc. (NASDAQ:PGNX)
     Regeneron Pharmaceuticals (NASDAQ:REGN)
     Respironics Inc. (NASDAQ:RESP)
     Sepracor Inc. (NASDAQ:SEPR)
     Theravance Inc. (NASDAQ:THRX)
     United Therapeutics Corp. (NASDAQ:UTHR)
     Valeant Pharmaceuticals Int'l (NYSE:VRX)
     Vertex Pharmaceuticals (NASDAQ:VRTX)
    Add
     Adolor Corp. (NASDAQ:ADLR)
     ALLOS THERAPEUTICS INC. (NASDAQ:ALTH)
     Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
     Alpharma Inc. (NYSE:ALO)
     Altus Pharmaceuticals Inc. (NASDAQ:ALTU)
     AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)
     ANGIOTECH PHARMACEUTICALS (NASDAQ:ANPI)
     Ark Therapeutics (LSE:AKT.L)
     Bavarian Nordic A/S (Copenhagen: BAVA.CO)
     Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD)
     Cardiome Pharma Corp. (NASDAQ:CRME)
     Coventry Health Care Inc. (NYSE:CVH)
     CRUCELL-ADR (NASDAQ:CRXL)
     CUBIST PHARMACEUTICALS INC. (NASDAQ:CBST)
     Discovery Laboratories Inc. (NASDAQ:DSCO)
     Eisai Co. Ltd. 
     Encysive Pharmaceuticals Inc. (NASDAQ:ENCY)
     Enzo Biochem Inc. (NYSE:ENZ)
     ENZON PHARMACEUTICALS INC. (NASDAQ:ENZN)
     Exelixis Inc. (NASDAQ:EXEL)
     Flamel Technologies (NASDAQ:FLML)
     Illumina Inc. (NASDAQ:ILMN)
     Incyte Corporation (NASDAQ:INCY)
     Integra LifeSciences Holdings (NASDAQ:IART)
     Meda AB (Stockholm: MEDAA.ST)
     Mitsubishi Tanabe Pharma 
     Taisho Pharmaceutical Co., Ltd. 


    Dermatology and Wound Index (HRW)
    Drop
     Shire PLC (ADR) (NASDAQ:SHPGY)
     SkyePharma Plc 
    Add
     Standard Chemical & Pharm. Co., Ltd. 
     Taisho Pharmaceutical Co., Ltd. 

    Diagnostics Index (HHD)
    Drop
     CR Bard, Inc. (NYSE:BCR)
     IDEXX Laboratories (NASDAQ:IDXX)
    Add
     Bruker Corporation (NASDAQ:BRKR)
     Halozyme Therapeutic (NASDAQ:HALO)

    Emerging Cancer Index (HHJ)
    Drop
     Adventrx Pharmaceuticals, Inc. (AMEX:ANX)
     Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX)
    Add
     Dyanvax Technologies (NASDAQ:DVAX)
     Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

    Enabling Technologies Index (HHV)
    Drop
     Hillenbrand Industries (NYSE:HB)
    Add
     Eurand N.V. (NASDAQ:EURX)

     GI/Gender Index (HHU)
    Drop
     AEterna Zentaris (NASDAQ:AEZS)
     King Pharmaceuticals (NYSE:KG)
     Nastech Pharmaceutical (NASDAQ:NSTK)
    Add
     Columbia Laboratories Inc. (NASDAQ:CBRX)
     Eisai Co. Ltd. 
     Mylan, Inc. (NYSE:MYL)

    Metabolic-Endocrine Disorders Index (HHM)
    Drop
     Depomed Inc. (NASDAQ:DEPO)
     Emisphere Technologies Inc. (NASDAQ:EMIS)
     Flamel Technologies SA ADS (NASDAQ:FLML)
     Hospira Inc. (NYSE:HSP)
     Human Genome Sciences, Inc. (NASDAQ:HGSI)
     Indevus Pharmaceuticals Inc. (NASDAQ:IDEV)
     Ipsen Ltd. 
     Nastech Pharmaceutical Co. (NASDAQ:NSTK)
     Nektar Therapeutics (NASDAQ:NKTR)
     NicOx S.A. 
     OSI Pharmaceuticals Inc. (NASDAQ:OSIP)
     ProStrakan Group Plc (LSE:PSK.L)
     Solvay S.A. (Brussels: SVYSY)
    Add
     Altus Pharmaceuticals Inc. (NASDAQ:ALTU)
     Amicus Therapeutics, Inc. (NASDAQ:FOLD)
     Biodel Inc. (NASDAQ:BIOD)
     CombinatoRx Inc. (NASDAQ:CRXX)
     GW Pharmaceuticals Plc (LSE:GWP.L)
     Incyte Corp. (NASDAQ:INCY)
     Orexigen Therapeutics, Inc. (NASDAQ:OREX)
     Repros Therapeutics Inc. (NASDAQ:RPRX)
     Sangamo BioSciences Inc. (NASDAQ:SGMO)
     Sirtris Pharmaceuticals, Inc. (NASDAQ:SIRT)
     SuperGen Inc. (NASDAQ:SUPG)
     Transition Therapeutics Inc. (NASDAQ:TTHI)
     XOMA Ltd. (NASDAQ:XOMA)

    Neuroscience Index (HHN)
    Drop
     Neurochem Inc. (NASDAQ:NRMX)
    Add
     Caraco Pharmaceutical Laboratories Ltd. (AMEX:CPD)

    Ophthalmology Index (HHZ)
    Drop
     Insite Vision Inc. (AMEX:ISV)
    Add
     King Pharmaceuticals (NYSE:KG)

    Patient Care Services Index (HHB)
    Drop
     Fresenius Medical Care (XETRA: FME.DE)
    Add
     Coventry Health Care Inc. (NYSE:CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at www.qedinternational.com

Source: QED International Associates Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here